Ex vivo-activated autologous lymph node lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ex vivo-activated autologous lymph node lymphocytes, covering 2019-10-29 to 2019-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]